Allianza de ENT / NOTICIAS & EVENTOS / Noticias
Noticias
Las últimas noticias de la Alianza de ENT.
Suscríbete a nuestro boletín semanal para recibir las últimas noticias sobre ENT.
Las últimas noticias de la Alianza de ENT.
Suscríbete a nuestro boletín semanal para recibir las últimas noticias sobre ENT.
Announcements | 15 de febrero de 2017
WHO EURO Public Health Panorama calls for the submission of papers for a special issue on obesity and unhealthy diets in the WHO European Region.
World Days | 3 de febrero de 2017
New guidance from WHO, launched ahead of World Cancer Day (4 February), aims to improve the chances of survival for people living with cancer by ensuring that health services can focus on diagnosing and treating the disease earlier.
Announcements | 1 de febrero de 2017
Among the developments arising during the 140th WHO EB, the list of candidates for the role of WHO Director General was shortened, preparations for the 2018 UN HLM on NCDs were discussed, and a recommendaiton was made for the 70th WHA to adopt a global action plan on the response to dementia.
Announcements | 1 de febrero de 2017
The 55th session of the Commission for Social Development opened today at UN Headquarters in New York. CSocD55 will focus on strategies for eradicating poverty to achieve sustainable development for all.
World Days | 31 de enero de 2017
This year, World Cancer Day is highlighting physical activity in the fight against cancer through the Support through Sport initiative.
Announcements | 26 de enero de 2017
Citizens with disabilities continue experiencing inequalities in enjoying their right to health both home and abroad, according to research findings presented this week at the European Parliament.
Announcements | 25 de enero de 2017
Public health advocates convened recently in Barbados, agreed on the need to work together to protect the tax on sugar-sweetened beverages in place since September 2015 in the country.
Announcements | 18 de enero de 2017
The NCD Alliance welcomes major announcement by a coalition of biopharmaceutical companies to address the barriers of access on NCDs in low- and lower-middle income countries.